
FGF Receptor Inhibitors: Small Molecules and Peptides
FGF activity is mediated by a family of type I transmembrane tyrosine kinases, which undergo dimerization and autophosphorylation after ligand binding. Five distinct genes encode closely related FGF receptors, FGF R1 through 5. FGF Rs contain three Ig-like domains and a stretch of acidic residues between the first and second Ig-like domains. FGF R1, 2, 3, and -4 have a cytoplasmic split tyrosine-kinase domain, but FGF R5 does not. Multiple forms of FGF R1, 2, and 3 are generated by alternative splicing
9 results for "FGF Receptor Inhibitors Small Molecules and Peptides" in Products
Product Action
Conjugates
Low Endotoxin
Sample Size
Citations
Reviews
FGF Receptor Inhibitors: Small Molecules and Peptides
FGF activity is mediated by a family of type I transmembrane tyrosine kinases, which undergo dimerization and autophosphorylation after ligand binding. Five distinct genes encode closely related FGF receptors, FGF R1 through 5. FGF Rs contain three Ig-like domains and a stretch of acidic residues between the first and second Ig-like domains. FGF R1, 2, 3, and -4 have a cytoplasmic split tyrosine-kinase domain, but FGF R5 does not. Multiple forms of FGF R1, 2, and 3 are generated by alternative splicing
9 results for "FGF Receptor Inhibitors Small Molecules and Peptides" in Products
Potent FGFR and VEGFR inhibitor
Chemical Name : | 2-[(1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-4-methyl-1H-pyrrole-3-propanoic acid |
Purity : | ≥95% (HPLC) |
Potent VEGFR, PDGFR and FGFR inhibitor
Chemical Name : | Methyl (Z)-3-[[[4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene]-2-oxoindoline-6-carboxylate |
Purity : | ≥98% (HPLC) |
Potent, irreversible FGFR inhibitor
Chemical Name : | N-(3-((3-(2,6-dichloro-3,5-dimethoxyphenyl)-7-(4-(diethylamino)butylamino)-2-oxo-3,4-dihydropyrimido[4,5-d]pyrimidin-1(2H)-yl)methyl)phenyl)acrylamide |
Purity : | ≥96% (HPLC) |
Selective FGFR inhibitor
Chemical Name : | N-[6-(2,6-Dichlorophenyl)-2-[[4-(diethylamino)butyl]amino]pyrido[2,3-d]pyrimidin-7-yl]-N'-(1,1-dimethylethyl)urea |
Purity : | ≥97% (HPLC) |
FGFR1 and -3 inhibitor
Chemical Name : | N-[2-[[4-(Diethylamino)butyl]amino]-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-N'-(1,1-dimethylethyl)urea |
Purity : | ≥98% (HPLC) |
PDGFR, VEGFR and FGFR inhibitor
Alternate Names : | TSU68, Orantinib |
Chemical Name : | 5-[1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid |
Purity : | ≥99% (HPLC) |
Potent inhibitor of VEGFR, PDGFR and FGFR
Chemical Name : | 4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]quinazoline |
Purity : | ≥98% (HPLC) |
Potent multi-kinase and pan-Bcr-Abl inhibitor
Alternate Names : | Ponatinib |
Chemical Name : | 3-(2-Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-benzamide |
Purity : | ≥98% (HPLC) |
Potent Src inhibitor; also inhibits FGFR1, PDGFRβ and Wee1
Chemical Name : | 6-(2,6-Dichlorophenyl)-2-[[4-[2-(diethylamino)ethoxy]phenyl]amino]-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one dihydrochloride |
Purity : | ≥99% (HPLC) |